Huntington's disease (HD) is an inherited neurodegenerative disease caused by expansion
of a polyglutamine tract in the huntingtin protein. Transcriptional dysregulation has been …

Background Levodopa is the most effective therapy for Parkinson's disease, but chronic
treatment is associated with the development of potentially disabling motor complications. …

Parkinson's disease (PD) progresses relentlessly and affects five million people worldwide.
Laboratory tests for PD are critically needed for developing treatments designed to slow or …

We describe a novel mechanism for vital fluorescent dye entry into sensory cells and neurons:
permeation through ion channels. In addition to the slow conventional uptake of styryl …

Metabotropic glutamate receptors (mGluRs) couple the actions of glutamate to intracellular
second messenger systems through G-proteins. The mGluRs play an important role in the …

Dystonias comprise a group of movement disorders that are characterized by involuntary
movements and postures. Insight into the nature of neuronal dysfunction has been provided by …

Parkinson’s disease (PD) may start in the gut and spread to the brain. To investigate the role
of gut microbiome, we conducted a large-scale study, at high taxonomic resolution, using …

A diagnosis of motor Parkinson’s disease (PD) is preceded by a prolonged premotor phase
with accumulating neuronal damage. Here we examined the temporal relation between α-…

We studied afferents to the parabrachial nucleus (PB) from the spinal cord and the spinal
trigeminal nucleus pars caudalis (SNVc) in the rat by using the anterograde and retrograde …

Missense mutations in leucine-rich repeat kinase 2 (LRRK2) cause late-onset Parkinson's
disease (PD), and common genetic variation in LRRK2 modifies susceptibility to Crohn's …